CSL is investigating two potential new treatments for sickle cell disease: An injected monoclonal antibody designed to ...

The U.S. Food and Drug Administration is speeding up its review of an oral medicine for sickle cell disease that may fill a ...

Columnist Oluwatosin Adesoye once feared how sickle cell complications would affect her future, but they ended up opening ...

Wilson reflects on the fruits of progress in sickle cell advocacy, leading to a new generation of possibility.

Sickle cell disease (SCD) prognosis varies depending on disease severity and other factors, but the overall life expectancy for the inherited blood disorder has increased notably over recent decades.

Mutations in the HBB gene cause SCD by leading to the production of a faulty version of hemoglobin (the protein that helps red blood cells transport oxygen), which tends to clump inside red blood ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google For individuals living with sickle cell disease (SCD), daily life ...

Sickle cell disease (SCD) may be cured in some individuals by a stem cell transplant. There also are several approved therapies to help manage the condition and its related complications. Some of the ...

Casgevy (exagamglogene autotemcel) is now approved in the U.S. to treat children as young as 2 with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOCs). The U.S. Food and Drug ...

Beam Therapeutics plans to ask the U.S. Food and Drug Administration (FDA) to approve ristoglogene autogetemcel, or risto-cel, its single-dose, gene-edited cell therapy candidate for people with ...

A camp in North Carolina offers children living with sickle cell disease the chance to build confidence, independence, and emotional strength while connecting with others who also live with a chronic ...